By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Horizon Discovery today said that it has raised £11.3 million ($18.6 million) in a Series C round of financing.

The Cambridge, UK-based maker of research tools for personalized medicine and drug discovery said that the funds will be used to improve its core technology platforms, strengthen its intellectual property position, and expand into new disease areas outside of its historical focus on cancer.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.